section name header

Pronunciation

SOE-dee-um zir-KOE-nee-um SYE-kloe-SIL-i-kate

Classifications

Therapeutic Classification: hypokalemic, electrolyte modifiers

Pharmacologic Classification: cationic exchange resins

Indications

REMS


Action

  • Exchanges hydrogen and sodium ions for potassium ions in the intestine.
Therapeutic effects:
  • Reduction of serum potassium concentrations.

Pharmacokinetics

Absorption: Not systemically absorbed.

Distribution: Not distributed.

Metabolism/Excretion: Does not undergo metabolism; eliminated in the feces.

Half-Life: Unknown.

Time/Action Profile

( in serum potassium concentrations)
ROUTEONSETPEAKDURATION
PO1 hrunknown48 hr



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: edema

F and E: hypokalemia

GI: constipation

Interactions

Drug-drug:

Route/Dosage

Renal Impairment

Availability

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Lokelma